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Future Work
Papers can be linked by citation relationships. 
Claim C4 is supported by citing Zhao et al. 2006 
which in turn cites Lacor et al. 2004.
Fig 2: Argument Graph Across Papers
This chain of citations justifies the choice of 
biomarker materials: “PSD-95, a postsynaptic 
marker that has been reported to decrease early in 
neurodegeneration (Zhao et al., 2006)”. 
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Argument Analysis of Alzheimer’s Disease
Introduction
Experimental science papers can be difficult to 
understand. In Dr. Jodi Schneider's lab we studied the 
argumentation and logical reasoning within a paper in 
Alzheimer’s research.  Alzheimer’s disease is a form of 
dementia that affects 30 million people worldwide, and 
has no known cure. 
Understanding the reasoning of papers can help assess 
their quality, and could make it easier to translate or 
reuse scientific research. We use a new representation 
called micropublication (Clark et al. 2014) to visualize 
the structure of the multiple experiments. 
We used the paper “Propagation of Tau Pathology in a 
Model of Early Alzheimer’s Disease”. This paper 
describes how mouse models can be used to study 
Alzheimer’s disease. It is one of the top ten most 
influential Alzheimer's disease research papers selected 
by members of Journal of Alzheimer’s Disease. 
Methods
How to Create a Micropublication:
.
Results
We analyzed the paper “Propagation of Tau Pathology in a Model of Early Alzheimer’s Disease” (#1) through annotation (#2) and argument diagramming. 
The micropublication diagram (#4) provides an outline and summary for the paper and its claims. The authors’ main claim is that their mouse model helps 
understand the mechanism and progression of Alzheimer’s disease. In the micropublication below, C0 shows the main claim. We found 4 lines of 
argument supporting this claim, shown below as the four sub-claims C1, C2, C3, C4. The material (M), methods (m), and data (D) produce the sub-claims.
.
Case Study Paper: 
“Propagation of Tau 
Pathology in a Early 
Model of Alzheimer's 
disease”
Conclusions
We identified four lines of argument about how 
tau pathology in mice models is related to 
Alzheimer's disease in humans. We created a 
diagram of the logical reasoning presented in 
“Propagation of Tau Pathology in a Model of 
Early Alzheimer’s Disease”. 
This can make the role of research data and 
supporting evidence more clear. For instance, 
showing the dependencies between articles 
(Figure 2) could help identify possible logical 
inconsistencies in a network of scientific 
papers, and prioritize research for 
reproducibility experiments. Micropublications 
can also support more granular search and 
retrieval of aspects of scientific papers, such 
as the materials or methods used. 
In the future, the manual analysis conducted 
will help informatics researchers in the 
Schneider Lab develop a system to 
automatically extract arguments.
Annotations via hyothes.is.
Fig 1: Micropublication model for “Propagation of Tau Pathology in a Model of Early Alzheimer’s Disease”
Case Study Paper: 
“Propagation of Tau 
Pathology in a Early 
Model of Alzheimer's 
disease”
4. Create a Micropublication 
3. Diagram the reasoning and 
arguments of the scientific 
paper  
2. Annotate using 
http://hypothes.is
1. Identify a scientific 
research paper
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